Shift Cannabis Succeeds in Ohio Applications

Thursday, June 28, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

BOULDER, Colo., June 28, 2018 /PRNewswire/ -- This past week Shift Cannabis' clients and partners won five provisional

dispensary licenses in Ohio. We are proud to be one of three teams who will have the maximum five licenses allowed in the Ohio medical cannabis market.

There were 376 applications

submitted and only 56 dispensary licenses awarded. Of all the applicants, Shift had the top five scores. Dispensaries will be distributed across the state into four districts and over the next few years the Ohio medical cannabis market has the potential to reach $400 million in retail sales.

The state of Ohio permits the use of cannabis in oils, edibles and tinctures. While the law does allow vaping, it prohibits smokable cannabis. The state has set a September 8th deadline to have a fully operational market and physicians are expected to begin registering patients for the program in July.

"I am very proud of the Shift team's efforts in Ohio. As the value of doing business in a limited license state has increased, so has the complexity and competition for winning those licenses. This win is a great example of our ability to succeed in increasingly competitive and evolving legal cannabis markets."  - Edwin Fowler, President Shift Cannabis

Shift's continued success in winning licenses in ever competitive markets, including limited license states such as Ohio, demonstrates our ability to lead commercial expansion nationally.

This is a great next step in Shift's continued growth as we work to expand our footprint in every legal market.

Shift Cannabis - Founded in 2010 - #GenuineCannabis

For more information: Kate Dwyer Director Marketing at (617) 852-8238 or kate@shiftcannabis.com - www.shiftcannabis.com

 

Cision View original content:http://www.prnewswire.com/news-releases/shift-cannabis-succeeds-in-ohio-applications-300671832.html

SOURCE Shift Cannabis



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store